Diebold, Inc. (DBD) Reports Q1 Adj-EPS of 74c; Raises FY12 Outlook
Tweet
Share
E-mailGet Alerts DBD Hot Sheet
Price: $69.94 +3.14%
Financial Fact:
Total cost of sales: 424.9M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Total cost of sales: 424.9M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Diebold, Inc. (NYSE: DBD) reported Q1 EPS of $0.74, versus $0.23 reported last year. Revenue for the quarter came in at $698.49 million, versus $614.16 million reported last year.
Diebold, Inc. sees FY2012 EPS of $2.50-$2.70, versus prior guidance of $2.30-$2.50 and the consensus of $2.44.
For earnings history and earnings-related data on Diebold, Inc. (DBD) click here.
Diebold, Inc. sees FY2012 EPS of $2.50-$2.70, versus prior guidance of $2.30-$2.50 and the consensus of $2.44.
For earnings history and earnings-related data on Diebold, Inc. (DBD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- DA Davidson Reiterates Buy Rating on Box, Inc. (BOX) on Secular Tailwinds for Demand
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
